Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice

Brain Research

Volumn 980, Issue 2, 2003, Pages 213-220

  Kandere Grzybowska, Kristiana ^a   Gheorghe, Daniela ^a   Priller, Josef ^a,c   Esposito, Pamela ^a   Huang, Man ^a   Gerard, Norma ^b   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Dura; Mast cell; Migraine; Neurokinin 1 receptor; Stress; Vascular permeability

Indexed keywords

GLUCEPTATE TC 99M; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; DATA ANALYSIS; DURA MATER; EXTRAVASATION; FEMALE; IMMOBILIZATION STRESS; KNOCKOUT MOUSE; MALE; MAST CELL; MIGRAINE; MOUSE; NEUROGENIC INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; STRESS; WILD TYPE;

EID: 0037627980     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02975-5     Document Type: Article

References (58)

1. Andres K.H., VonDuring M., Muszynski K., Schmidt R.T. Nerve fibers and their terminals of the dura mater encephali of the rat. Anat. Embryol. (Berl. ). 175:1987;289-301.
2. Ansel J.C., Brown J.R., Payan D.G., Brown M.A. Substance P selectively activates TNF-α gene expression in murine mast cells. J. Immunol. 150:1993;4478-4485.
3. Beattie D.T., Beresford I.J., Connor H.E., Marshall F.H., Hawcock A.B., Hagan R.M., Bowers J., Birch P.J., Ward P. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist. Br. J. Pharmacol. 116:1995;3149-3157.
4. Beaujouan J.C., Saffroy M., Torrens Y., Glowinski J. Different subtypes of tachykinin NK(1) receptor binding sites are present in the rat brain. J. Neurochem. 75:2000;1015-1026.
5. Bjorling D.E., Jerde T.J., Zine M.J., Busser B.W., Saban M.R., Saban R. Mast cells mediate the severity of experimental cystitis in mice. J. Urol. 162:1999;231-236.
6. Bozic C.R., Lu B., Höpken U.E., Gerard C., Gerard N.P. Neurogenic amplification of immune complex inflammation. Science. 273:1996;1722-1725.
7. Cao T., Gerard N.P., Brain S.D. Use of NK1 knockout mice to analyze substance P-induced edema formation. Am. J. Physiol. 277:1999;R476-R481.
8. Cao Y.Q., Manthy P.W., Carlson E.J., Gillespie A., Epstein C.J., Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392:1998;390-393.
9. Chrousos G.P. Stressors, stress, and neuroendocrine integration of the adaptive. Response: The 1997 Hans Selye Memorial Lecture. Ann. N. Y. Acad. Sci. 851:1998;311-335.
10. Clifton V.L., Crompton R., Smith R., Wright I.M. Microvascular effects of CRH in human skin vary in relation to gender. J. Clin. Endocrinol. Metab. 87:2002;267-270.
11. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J.H., Laird J.M.A., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;394-397.
12. Delepine L., Aubineau P. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion. Exp. Neurol. 147:1997;389-400.
13. Deleu D., Hanssens Y., Worthing E.A. Symptomatic and prophylactic treatment of migraine:a critical reappraisal. Clin. Neuropharmacol. 21:1998;267-279.
14. Dimitriadou V., Buzzi M.G., Moskowitz M.A., Theoharides T.C. Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells. Neuroscience. 44:1991;97-112.
15. Dimitriadou V., Buzzi M.G., Theoharides T.C., Moskowitz M.A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience. 48:1992;187-203.
16. Dimitriadou V., Rouleau A., Trung Tuong M.D., Newlands G.J.F., Miller H.R.P., Luffau G., Schwartz J.-C., Garbarg M. Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience. 77:1997;829-839.
17. Esposito P., Gheorghe D., Kandere K., Pang X., Conally R., Jacobson S., Theoharides T.C. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888:2001;117-127.
18. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28:1990;183-187.
19. Goebel H., Czech N., Heinze-Kuhn A. Evidence of regional plasma extravasation in cluster headache using Tc-99m albumin SPECT. Cephalalgia. 20:2001;287.
20. Hardebo J.E. The involvement of trigeminal substance P neurons in cluster headache. A hypothesis. Headache. 24:1984;294-304.
21. 1 (substance P) receptor antagonists - why are they not analgesic in humans? Trends Pharmacol. Sci. 21:2000;244-246.
22. Huang M., Pang X., Letourneau L., Boucher W., Theoharides T.C. Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in apolipoprotein E knockout mice. Cardiovasc. Res. 55:2002;150-160.
23. Janiszewski J., Bienenstock J., Blennerhassett M.G. Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am. J. Physiol. 267:1994;C138-C145.
24. Jasmin L., Janni G., Ohara P.T., Rabkin S.D. CNS induced neurogenic cystitis is associated with bladder mast cell degranulation in the rat. J. Urol. 164:2000;852-855.
25. Keller J.T., Dimlich R.V., Zuccarello M., Lanker L., Strauss T.A., Fritts M.J. Influence of the sympathetic nervous system as well as trigeminal sensory fibres on rat dural mast cells. Cephalalgia. 11:1991;215-221.
26. Kowalski M.L., Kaliner M.A. Neurogenic inflammation, vascular permeability, and mast cells. J. Immunol. 140:(11):1988;3905-3911.
27. Krumins S.A., Broomfield C.A. Evidence of NK1 and NK2 tachykinin receptors and their involvement in histamine release in a murine mast cell line. Neuropeptides. 21:1992;65-72.
28. Lutz E., Chan W., Track N.S., Goth A., Said S.I. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature. 275:1978;661-662.
29. MacQueen G., Marshall J., Perdue M., Siegel S., Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science. 243:1989;83-85.
30. Mannaioni P.F., Masini E., Pistelli A., Salvemini D., Vane J.R. Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release. Int. J. Tissue React. 13:1991;271-278.
31. Markowitz S., Saito K., Moskowitz M.A. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. 7:1987;4129-4136.
32. Morteau O., Lu B., Gerard C., Gerard N.P. Hemokinin 1 is a full agonist at the substance P receptor. Nat. Immunol. 2:2001;1088.
33. Moskowitz M.A. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 43:1993;S16-S20.
34. Mousli M., Bronner C., Landry Y., Bockaert J., Rouot B. Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett. 259:1990;260-262.
35. Mousli M., Bueb J.-L., Bronner C., Rouot B., Landry Y. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol. Sci. 11:1990;358-362.
36. O'Shaughnessy C.T., Connor H.E. Investigation of the role of tachykinin NK1, NK2 receptors and CGRP receptors in neurogenic plasma protein extravasation in dura mater. Eur. J. Pharmacol. 263:1994;193-198.
37. Okada T., Hirayama Y., Kishi S., Miyayasu K., Hiroi J., Fujii T. Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells. Inflamm. Res. 48:1999;274-279.
38. Olesen J., Thomsen L.L., Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci. 15:1994;149-153.
39. Olness K., Hall H., Rozniecki J.J., Schmidt W., Boucher W., Theoharides T.C. Mast cell activation in children with migraine before and after training in self-regulation. Headache. 39:1999;101-107.
40. Ottosson A., Edvinsson L. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia. 17:1997;166-174.
41. Papagallo M., Szabo Z., Esposito G. Imaging neurogenic inflammation in patients with migraine headaches. Neurology. 52:1999;A274-A275.
42. Rivest S., Laflamme N., Nappi R.E. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J. Neurosci. 15:1995;2680-2695.
43. Rozniecki J.J., Dimitriadou V., Lambracht-Hall M., Pang X., Theoharides T.C. Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo. Brain Res. 849:1999;1-15.
44. Rozniecki J.J., Letourneau R., Sugiultzoglu M., Spanos C., Gorbach J., Theoharides T.C. Differential effect of histamine-3 receptor active agents on brain but not peritoneal mast cell activation. J. Pharmacol. Exp. Ther. 290:1999;1-9.
45. Russell M., Dark K.A., Cummins R.W., Ellman G., Callaway E., Peeke H.V. Learned histamine release. Science. 225:1984;733-734.
46. Saban R., Gerard N.P., Saban M.R., Nguyen N.B., DeBoer D.J., Wershil B.K. Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism. Am. J. Physiol. Renal Physiol. 283:2002;F616-629.
47. Saban R., Saban M.R., Nguyen N.B., Lu B., Gerard C., Gerard N.P., Hammond T.G. Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis. Am. J. Pathol. 156:2000;775-780.
48. Seabrook G.R., Shepheard S.L., Williamson D.J., Tyrer P., Rigby M., Cascieri M.A., Harrison T., Hargreaves R.J., Hill R.G. L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays. Eur. J. Pharmacol. 317:1996;129-135.
49. Shepheard S.L., Williamson D.J., Hill R.G., Hargreaves R.J. The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br. J. Pharmacol. 108:1993;11-12.
50. Singh L.K., Pang X., Alexacos N., Letourneau R., Theoharides T.C. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin and substance P: a link to neurogenic skin disorders. Brain Behav. Immunol. 13:1999;225-239.
51. Suzuki R., Furuno T., McKay D.M., Wolvers D., Teshima R., Nakanishi M., Bienenstock J. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J. Immunol. 163:1999;2410-2415.
52. Theoharides T.C. The mast cell: a neuroimmunoendocrine master player. Int. J. Tissue React. 18:1996;1-21.
53. Theoharides T.C., Singh L.K., Boucher W., Pang X., Letourneau R., Webster E., Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology. 139:1998;403-413.
54. Theoharides T.C., Spanos C.P., Pang X., Alferes L., Ligris K., Letourneau R., Rozniecki J.J., Webster E., Chrousos G. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology. 136:1995;5745-5750.
55. Williams R.M., Bienenstock J., Stead R.H. Mast cells: the neuroimmune connection. Chem. Immunol. 61:1995;208-235.
56. Yano H., Wershil B.K., Arizono N., Galli S.J. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J. Clin. Immunol. 84:1989;1276-1286.
57. Zhang Y., Lu L., Furlonger C., Wu G.E., Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1:2000;392-397.
58. Zimmer A., Zimmer A.M., Baffi J., Reynolds K., Usdin T., Palkovits M., Mezey E. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc. Natl. Acad. Sci. USA. 95:1998;2630-2635.